Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
19 and Pacific is a San Diego-based life science venture studio and investment firm dedicated to founding and building transformative biotechnology companies. The firm was established by a team of seasoned industry executives, including Faheem Hasnain and Sheila Gujrathi, who previously led successful ventures such as Receptos and Gossamer Bio. 19 and Pacific leverages its deep operational, clinical, and financial expertise to identify high-potential scientific innovations and provide the necessary leadership and capital to bring them to fruition. The studio focuses on creating companies that address significant unmet medical needs across various therapeutic areas, including immunology and oncology. By providing a hands-on approach to company building, 19 and Pacific aims to accelerate the delivery of next-generation medicines to patients. The firm operates as an operator-led incubator, often taking active management roles in its portfolio companies during their early stages.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 19 And Pacific.